作者
Thomas W Samuelson, David F Chang, Robert Marquis, Brian Flowers, K Sheng Lim, Iqbal Ike K Ahmed, Henry D Jampel, Tin Aung, Alan S Crandall, Kuldev Singh, Tom Walters, Jason Jones, Steven D Vold, Stephen E Smith, Gary Foster, Brennan P Greene, Dan B Tran, Husam Ansari, Kenneth Olander, Neil Atodaria, Cathleen McCabe, Richard Lewis, Mujtaba Qazi, Quang Nguyen, Edward Meier, David Godfrey, Mohammed El Mallah, Jason Levine, C Stark Johnson, E Randy Craven, Richard D Hawkins, William Clifford, Inder Paul Singh, Y Ralph Chu, Alan C Crandall, Douglas Rhee, Jose Manuel Larrosa Poves, Marek Rekas, Robert Edward T Ang, Sebastian Gagne, Leon Au, Michael Dorey, Marina Ramirez, Stefano Gandolfi, Julian Garcia-Feijoo, David Broadway, Norbert Pfeiffer
发表日期
2019/1/1
期刊
Ophthalmology
卷号
126
期号
1
页码范围
29-37
出版商
Elsevier
简介
Objective
To compare cataract surgery with implantation of a Schlemm canal microstent with cataract surgery alone for the reduction of intraocular pressure (IOP) and medication use after 24 months.
Design
Prospective, multicenter, single-masked, randomized controlled trial.
Participants
Subjects with concomitant primary open-angle glaucoma (POAG), visually significant cataract, and washed-out modified diurnal IOP (MDIOP) between 22 and 34 mmHg.
Methods
Subjects were randomized 2:1 to receive a single Hydrus Microstent (Ivantis, Inc, Irvine, CA) in the Schlemm canal or no stent after uncomplicated phacoemulsification. Comprehensive eye examinations were conducted 1 day, 1 week, and 1, 3, 6, 12, 18, and 24 months postoperatively. Medication washout and MDIOP measurement were repeated at 12 and 24 months.
Main Outcome Measures
The primary and secondary effectiveness end points were the …
学术搜索中的文章
TW Samuelson, DF Chang, R Marquis, B Flowers… - Ophthalmology, 2019